Follow the people · Insider
Shriram Revankar
Shriram Revankar files insider transactions with the SEC as a svp, advanced technology group of Dolby Laboratories (DLB). We hold 3 disclosed purchases and sales filed since 17 May 2022, 1 of them in the last 90 days.
- Files forDLB
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 16 May 2022 — 14 August 2026SVP, Advanced Technology Group · Dolby Laboratories (DLB)30 Form 4 lines · source: SEC Form 4
Everything they disclosed
30 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,000 shares of Dolby LaboratoriesSEC Form 418 August 2026Class A Common Stock · traded 14 August 2026 · filed 18 August 2026
- ▼ sold on the open market 3,000 shares of Dolby LaboratoriesSEC Form 419 May 2026Class A Common Stock · traded 15 May 2026 · filed 19 May 2026
- had shares withheld for tax on 4,329 shares of Dolby LaboratoriesSEC Form 419 May 2026Class A Common Stock · traded 18 May 2026 · filed 19 May 2026
- ▼ sold on the open market 3,000 shares of Dolby LaboratoriesSEC Form 417 February 2026Class A Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 3,000 shares of Dolby LaboratoriesSEC Form 417 February 2026Class A Common Stock · traded 17 February 2026 · filed 17 February 2026
- was granted 11,308 shares of Dolby Laboratories (a derivative holding)SEC Form 417 December 2025Performance-Based Restricted Stock Unit · traded 15 December 2025 · filed 17 December 2025
- was granted 49,800 shares of Dolby Laboratories (a derivative holding)SEC Form 417 December 2025Employee Stock Option (Right to Buy) · traded 15 December 2025 · filed 17 December 2025
- exercised options over 3,412 shares of Dolby Laboratories (a derivative holding)SEC Form 417 December 2025Performance-Based Restricted Stock Unit · traded 15 December 2025 · filed 17 December 2025
- was granted 22,617 shares of Dolby LaboratoriesSEC Form 417 December 2025Class A Common Stock · traded 15 December 2025 · filed 17 December 2025
- exercised options over 3,412 shares of Dolby LaboratoriesSEC Form 417 December 2025Class A Common Stock · traded 15 December 2025 · filed 17 December 2025
- had shares withheld for tax on 4,961 shares of Dolby LaboratoriesSEC Form 417 December 2025Class A Common Stock · traded 15 December 2025 · filed 17 December 2025
- had shares withheld for tax on 2,285 shares of Dolby LaboratoriesSEC Form 417 December 2025Class A Common Stock · traded 16 December 2025 · filed 17 December 2025
- ▼ sold on the open market 3,000 shares of Dolby LaboratoriesSEC Form 424 November 2025Class A Common Stock · traded 21 November 2025 · filed 24 November 2025
- ▼ sold on the open market 7,000 shares of Dolby LaboratoriesSEC Form 426 August 2025Class A Common Stock · traded 22 August 2025 · filed 26 August 2025
- had shares withheld for tax on 4,329 shares of Dolby LaboratoriesSEC Form 420 May 2025Class A Common Stock · traded 16 May 2025 · filed 20 May 2025
- was granted 9,070 shares of Dolby Laboratories (a derivative holding)SEC Form 418 December 2024Performance-Based Restricted Stock Unit · traded 16 December 2024 · filed 18 December 2024
- was granted 31,890 shares of Dolby Laboratories (a derivative holding)SEC Form 418 December 2024Employee Stock Option (Right to Buy) · traded 16 December 2024 · filed 18 December 2024
- was granted 18,141 shares of Dolby LaboratoriesSEC Form 418 December 2024Class A Common Stock · traded 16 December 2024 · filed 18 December 2024
- had shares withheld for tax on 3,364 shares of Dolby LaboratoriesSEC Form 418 December 2024Class A Common Stock · traded 16 December 2024 · filed 18 December 2024
- had shares withheld for tax on 4,409 shares of Dolby LaboratoriesSEC Form 417 May 2024Class A Common Stock · traded 16 May 2024 · filed 17 May 2024
- was granted 8,074 shares of Dolby Laboratories (a derivative holding)SEC Form 419 December 2023Performance-Based Restricted Stock Unit · traded 15 December 2023 · filed 19 December 2023
- was granted 28,305 shares of Dolby Laboratories (a derivative holding)SEC Form 419 December 2023Employee Stock Option (Right to Buy) · traded 15 December 2023 · filed 19 December 2023
- was granted 16,149 shares of Dolby LaboratoriesSEC Form 419 December 2023Class A Common Stock · traded 15 December 2023 · filed 19 December 2023
- had shares withheld for tax on 1,309 shares of Dolby LaboratoriesSEC Form 419 December 2023Class A Common Stock · traded 15 December 2023 · filed 19 December 2023
- had shares withheld for tax on 4,285 shares of Dolby LaboratoriesSEC Form 418 May 2023Class A Common Stock · traded 16 May 2023 · filed 18 May 2023
- was granted 5,278 shares of Dolby Laboratories (a derivative holding)SEC Form 416 December 2022Performance-Based Restricted Stock Unit · traded 15 December 2022 · filed 16 December 2022
- was granted 19,006 shares of Dolby Laboratories (a derivative holding)SEC Form 416 December 2022Employee Stock Option (Right to Buy) · traded 15 December 2022 · filed 16 December 2022
- was granted 10,557 shares of Dolby LaboratoriesSEC Form 416 December 2022Class A Common Stock · traded 15 December 2022 · filed 16 December 2022
- was granted 69,412 shares of Dolby Laboratories (a derivative holding)SEC Form 417 May 2022Employee Stock Option (right to buy) · traded 16 May 2022 · filed 17 May 2022
- was granted 48,936 shares of Dolby LaboratoriesSEC Form 417 May 2022Class A Common Stock · traded 16 May 2022 · filed 17 May 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.